eBooks & Guides

Going small to win big: Fragment-based screening in drug discovery

Issue link: https://resources.nanotempertech.com/i/1133236

Contents of this Issue

Navigation

Page 12 of 20

13 Thermal Shift Assay Ligand binding changes the temperature at which a protein unfolds when heated — this is the principle behind thermal shi assay (TSA). It's a rapid and inexpensive means of screening for binding, because it can be performed with a simple qPCR system on up to thousands of compounds per day. Changes in unfolding behavior are detected by monitoring the binding of fluorophores to hydrophobic portions of a protein which become exposed as the protein denatures. A shi in melting temperature indicates a binding event or hit. Various factors affect the magnitude of the thermal shi besides the affinity of the ligand at the melting temperature. The thermodynamics of protein unfolding play a major role, and varies for different proteins 20 . Although TSA requires only small amounts of protein, the weak binding typical of fragments may not rise to the level of detection by this technique. Because both false positives and negatives are common occurrences, use of TSA with larger compounds is more practical 9 . For crystallization, this technique has utility in identifying ligands that stabilize a protein 15 and for screening suitable stabilizing buffers 24 . Most importantly, TSA doesn't truly provide quantitative data on binding affinity of ligands, meaning that calculation of K d is not possible using these indirect methods. Straightforward, label-free and in solution measurement of changes in melting temperatures due to binding events Only provides a qualitative assessment of interactions (K d isn't calculated), not ideal for weak interactions common of fragments

Articles in this issue

view archives of eBooks & Guides - Going small to win big: Fragment-based screening in drug discovery